Free Ophthalmology CME

  • FREE

    Healio Free Ophthalmology CME

    Find out what over 50,000 of your colleagues already know. Earn credits faster and easier with Healio CME.

    See full details chevron_right
    • Cost: Free
    • Credit hours: Varies
  • FREE

    Glaucoma: best practices and the emerging treatment landscape

    Activity Description / Statement of Need:

    In this online, self-learning activity:

    Glaucoma, a heterogeneous disease leading to progressive damage to the optic nerve, causes irreversible vision loss and affects approximately 64 million people worldwide.The prevalence of glaucoma is increasing, and more than 100 million people will have glaucoma by 2040. Approximately half of all individuals with glaucoma are unaware of their condition due to the asymptomatic nature of the disease. Although the incidence of glaucoma-related blindness has decreased over the last 20 years, thanks to effective management strategies, 13% to 40% of people with glaucoma still develop unilateral or bilateral blindness, typically at a rate of 1.1% per year.

    Target Audience:

    The following healthcare professionals: ophthalmologists; physician assistants, nurse practitioners,  and any other healthcare professionals with an interest in or who clinically encounter patients with glaucoma.

    See full details chevron_right
    • Cost: Free
    • Credit hours: .75
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 02/11/2022
    • Expiration of CME credit: 02/11/2024
  • FREE

    CME: Glaucoma: optimizing pharmacotherapeutic management strategies

    Glaucoma, a heterogeneous disease leading to progressive damage to the optic nerve, causes irreversible vision loss and affects up to six million people in the U.S., and just as many worldwide have glaucoma-related bilateral blindness. The prevalence of glaucoma is increasing, and more than 100 million people across the globe will have glaucoma by 2040. Approximately half of all individuals with glaucoma are unaware of their condition due to the asymptomatic nature of the disease. Although the incidence of glaucoma-related blindness has decreased over the last 20 years thanks to effective management strategies, 13% to 40% of people with glaucoma still develop unilateral or bilateral blindness, typically at a rate of 1.1% per year.

    By the end of the session the participant will be able to:

    • Individualize intraocular pressure targets based on known risk factors and patient-specific characteristics, and optimize assessment of intraocular pressure profiles to readily identify peaks and fluctuations
    • Identify first-line pharmacotherapies, laser therapies, and glaucoma implants for lowering intraocular pressure, and select appropriate monotherapies and combination therapies for patients
    • Discuss present and emerging pharmacotherapies currently in clinical development and their mechanisms of action, and apply those therapies to patient cases
    • Describe barriers to care in the treatment of patients with glaucoma and what clinicians may do to aide patients in circumventing them

    Target Audience:

    Healthcare professionals (HCPs) including: comprehensive ophthalmologists and retinal specialists; physician assistants and nurse practitioners who practice in ophthalmology; and any other HCPs with an interest in or who clinically encounter patients with glaucoma.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 2/17/2020
    • Expiration of CME credit: 2/17/2022
  • FREE

    CME: Glaucoma: Updates from the AAO 2019 Annual Meeting

    Glaucoma, a heterogeneous disease leading to progressive damage to the optic nerve, causes irreversible vision loss and affects up to six million people in the U.S., and just as many worldwide have glaucoma-related bilateral blindness. The prevalence of glaucoma is increasing, and more than 100 million people across the globe will have glaucoma by 2040. Approximately half of all individuals with glaucoma are unaware of their condition due to the asymptomatic nature of the disease. Although the incidence of glaucoma-related blindness has decreased over the last 20 years thanks to effective management strategies, 13% to 40% of people with glaucoma still develop unilateral or bilateral blindness, typically at a rate of 1.1% per year.

    By the end of the session the participant will be able to:

    • Summarize the most impactful findings at the AAO 2019 meeting relating to glaucoma, including diagnostic testing, therapeutic success, and emerging therapies, and apply that knowledge to patients with different forms of glaucoma
    • Recall the results from the Horizon, LiGHT, and OHTS studies
    • List conditions that can masquerade as normal-tension glaucoma (NTG) and the role of systemic blood pressure in evaluation and management of NTG
    • Summarize the role of the following in glaucoma: hemoglobin video imaging, bimatoprost sustained-release implant, and the microshunt technology

    Target Audience:

    HCPs including: comprehensive ophthalmologists and retinal specialists; physician assistants and nurse practitioners who practice in ophthalmology; and any other HCPs with an interest in or who clinically encounter patients with glaucoma.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 04/10/2020
    • Expiration of CME credit: 04/10/2021
  • FREE

    Glaucoma: Therapeutic updates best practices and barriers to effective care

    Activity Description / Statement of Need:

    In this online, self-learning activity:

    Glaucoma, a heterogeneous disease leading to progressive damage to the optic nerve, causes irreversible vision loss and affects approximately 64 million people worldwide.The prevalence of glaucoma is increasing, and more than 100 million people will have glaucoma by 2040. Approximately half of all individuals with glaucoma are unaware of their condition due to the asymptomatic nature of the disease. Although the incidence of glaucoma-related blindness has decreased over the last 20 years, thanks to effective management strategies, 13% to 40% of people with glaucoma still develop unilateral or bilateral blindness, typically at a rate of 1.1% per year.

    Target Audience:

    The following healthcare professionals: Ophthalmologists; physician assistants, nurse practitioners, nurses, and pharmacists with an interest in ophthalmology or diseases affecting the eye; and any other healthcare professionals with an interest in or who clinically encounter patients with glaucoma.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 04/24/2021
    • Expiration of CME credit: 04/24/2023